Clin2
NCT07433426Possibly a fitRecruiting

Shigella infection treatment study for young children

Diarrhea InfectiousShigellaGrowth & Development

Treatments studied

Part of Digestive system, Infections clinical trials.

This study tests how well a recommended treatment works for children aged 6 months to 5 years who have diarrhea caused by Shigella bacteria. It aims to find the best way to help children recover faster.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
700 people
Ages
6 months to 4.9 years
Study type
Interventional

Who can take part

  • Your child is between 6 months and 5 years old.
  • Your child has watery diarrhea and tested positive for Shigella.
  • You live in the area where the study is taking place.
  • You are willing to bring your child for follow-up visits and provide samples.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07205926Recruiting· Phase 1
Testing a new Shigella vaccine in healthy adults

This trial tests a new Shigella vaccine in healthy adults to see if it is safe and creates a good immune response. It is a first-in-human study, meaning this is the first time the vaccine is given to people.

Cincinnati, Ohio
NCT07049159Recruiting· Phase 2
Testing a new oral vaccine to prevent shigella and ETEC infection

This trial tests an oral vaccine designed to protect against two common causes of severe diarrhea: shigella and ETEC bacteria. Healthy adults aged 18 to 50 will receive the vaccine and later be exposed to the bacteria to see if it works.

Baltimore, Maryland
NCT07451171Recruiting· Phase 2
Comparing antibiotics for gut bacteria in children

This study compares three different antibiotics to treat small intestine bacterial overgrowth (an overgrowth of bacteria in the gut) in children in Bangladesh. It aims to find which antibiotic works best.

Dhaka
NCT07666750Not yet recruiting· Phase 1/Phase 2
A shigella vaccine study for healthy people of different ages

This trial tests a new vaccine called IP-QSV to see if it is safe and creates an immune response against Shigella bacteria, a common cause of diarrhea. It is for healthy adults, adolescents, children, and infants.

NCT05959616Recruiting· Phase 1
Study of controlled Shigella infection in Kenyan adults

This Phase 1 study gives a carefully measured dose of Shigella sonnei to healthy adults to learn about the infection’s safety and how the body responds. It may help researchers build safer future tests or treatments, but it requires a hospital stay and many follow-up visits.

Kilifi
NCT07320716Not yet recruiting· Phase 2
Long-Term Protection Study of Shigella Vaccine in Children

This study checks how long the altSonflex1-2-3 Shigella vaccine protects children, by looking at children who already received it in earlier studies about a year ago.

Hear when a new Diarrhea Infectious trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.